Finance

Fytexia invests in Vital Solutions for health ingredients

For Fytexia, this financial investment comes two years after the acquisition of BNatural, the European leader in brown propolis extract

Breaking News

DSM-Firmenich announces placement of 6.7 million shares through accelerated bookbuild

The c. 6.7 million existing DSM-Firmenich ordinary shares through an accelerated bookbuild offers for a total amount of €733 million

Biofarma acquires US Pharma Lab and focuses solely on nutraceuticals

This partnership marks the evolution of Biofarma Group into the first global CDMO solely focused on nutraceuticals

Fytexia invests in Vital Solutions for health ingredients

For Fytexia, this financial investment comes two years after the acquisition of BNatural, the European leader in brown propolis extract

Nutraceuticals: a major revenue opportunity for pharma companies

There isn’t a single industry that hasn’t been affected by global economic disruptions in recent years. When searching for new revenue opportunitie...

TopGum signs agreement to purchase PharmItBe

The company will use PharmItBe’s fully equipped, FDA certified laboratory to access comprehensive chemical-analytical services

Royal DSM enters acquisition negotiations with Adare

DSM anticipates being able to rapidly extend the availability of Adare Biome's Lactéol for people through its B2C unit, i-Health

Turning the corner: practitioner channel for supplements offers growth and value

Having addressed threats from resellers, channel enjoys renewed tailwinds, reports Bakley Smith, CFA, Director of VMS at Green Circle Capital Partners

Event preview: The return of Vitafoods Europe 2021!

The nutraceuticals community is set to reunite once more in a new hybrid event format, with in-person elements enabled by comprehensive Informa All...

ADM and Brightseed come together to identify bioactives

The companies, with ADM investing in Brightseed, will look to identify bioactives from microbe and plant interactions to develop the future of clin...

Seventure enters negotiations with Cerea to acquire Polaris

Polaris has a €30 million turnover ($32.8 million) and serves the food supplements, nutraceutical and infant nutrition markets

Value of consumer insights

Understanding consumers’ needs and desires is at the centre of successful healthcare products and is essential to business development. In this int...

COVID-19: Nutraceutical players respond

Euromed, Kaneka, Omya and Glatt speak about how they are dealing with the pandemic and their predictions about future supply and demand

Unibio secures $70m to grow fermentation U-Loop tech

The proceeds will be deployed to "enable Unibio’s vision of feeding the world’s growing population in a sustainable way"

How to choose an incubator for your nutraceutical business

The number of business accelerators and incubators is increasing, says Ben Jones, Marketing and Partnerships Manager, AberInnovation, adding that p...

Vantage Nutrition acquires ComboCap

This acquisition positions Vantage Nutrition as the only company in the world supplying Sidebyside health products to nutritional and pharmaceutica...

Keeping up with e-commerce expansion

Buying or selling products online is on the rise due to the convenience it offers to customers. Tom Egan of The Association for Packaging and Proce...